The Action Plan Draft for Consideration - PowerPoint PPT Presentation

1 / 60
About This Presentation
Title:

The Action Plan Draft for Consideration

Description:

Facilitate world trade and the alleviation of poverty by reducing the impact of ... Who should Fund Research? ... 1.3 Wildlife Diseases (1-3-04, 1-1-05) ... – PowerPoint PPT presentation

Number of Views:44
Avg rating:3.0/5.0
Slides: 61
Provided by: jims171
Category:

less

Transcript and Presenter's Notes

Title: The Action Plan Draft for Consideration


1
European Technology Platform for Global Animal
Health (ETPGAH)
  • The Action Plan Draft for Consideration
  • Steering Council, April 19th, 2007

April 19th, 2007 Jim Scudamore, Consultant to the
ETPGAH
2
ETP Global Animal HealthAction plan
  • Introduction
  • Developing the action plan
  • Structure of the Action Plan
  • Chapter 1 Introduction
  • Chapter 2 Themes
  • Chapter 3 Priority Diseases
  • Way Forward

3
ETP Global Animal HealthAction plan
  • Introduction
  • Developing the action plan
  • Overview of the Action Plan
  • Chapter 1 Introduction
  • Chapter 2 Themes
  • Chapter 3 Priority Diseases
  • Way Forward

4
European Technology Platform for Global Animal
HealthWhere are we now?
Stakeholders, led by industry, come together
to agree on a common vision for the technology
Stakeholders, define a Strategic Research
Agenda setting the necessary mid- to longterm
objectives
Stakeholders, implement the Strategic
Research Agenda with the mobilisation of
significant human and financial resources
Implementation Plan detailed, roadmap,
quantify, identify funding sources creation of a
financial working group Launch June 2007
Vision paper EU TP Global Animal Health
Final version August 2005
Strategic Research Agenda Published May 2006
5
ETP Global Animal HealthThe Vision Aim
  • To facilitate and accelerate the development and
    distribution of the most effective tools for
    controlling animal diseases of major importance
    to Europe and the rest of the world, thereby
    improving human and animal health, food safety
    and quality, animal welfare, and market access,
    contributing to achieving the Millennium
    Development Goals.

6
ETP Global Animal HealthThe Strategic Research
Agenda
  • The SRA defines, in a very broad sense, the
    research necessary to deliver the Vision.
  • SRA has 2 overarching objectives-
  • to deliver new and improved tools for the control
    of major diseases and
  • to deliver the recommendations in the SRA which
    in turn will facilitate the development and
    delivery of new tools

Published May 2006
7
Deliverables - 1
  • Protect Europe from the incursion of epidemic
    animal diseases and zoonoses eg. Avian Influenza,
    Bluetongue
  • Deal rapidly and effectively with disease
    outbreaks in Europe should they occur.
  • Facilitate world trade and the alleviation of
    poverty by reducing the impact of these diseases
    in developing countries.
  • Reduce worldwide levels of disease and thereby
    indirectly protect Europe from disease spread by
    people or trade.
  • Bring more focus into research towards new tools
    for dealing with animal diseases.

8
Deliverables - 2
  • Increase the translation of technology into
    actual products.
  • Bring the developed tools faster to the market.
  • Ensure the legal and regulatory process is
    optimised to avoid unnecessary hurdles which
    limit disease control options and decrease the
    competitiveness of the industry.
  • Enable disease control authorities both within
    the EU and other countries to provide a swift and
    efficient reaction to new disease outbreaks.
  • Streamline research, development and regulatory
    efforts in order to ensure consumer safety
    without compromising the efficiency of product
    development.
  • View projects in the context of feasibility,
    applicability, need and availability of existing
    products within the time frame of the Strategic
    Research Agenda (SRA).

9
ETP Global Animal HealthThe SRA Six Themes
  • Strategically important issues
  • High societal relevance
  • Linked to Europes future growth,
    competitiveness, and sustainability
  • Dependant upon major research and
    technological advances
  • Medium to long-term scope
  • Important consequences for animal health
    research
  • Aligned with other Community policies and
    strategies
  • Significance for developing world

4 Improve Technology Transfer 17
5 Regulatory Societal Issues 8
1 Prioritise animal diseases 8
3 Fundamental research 5
6 Global Perspective 5
2 Gap Analysis 8
SRA
Finalised and submitted to the EU Commission in
May 2006
10
ETP Global Animal HealthImplementation of the SRA
  • SRA Provides a Roadmap
  • Research Requirements
  • Actions to achieve Aims not all research
  • Six Themes
  • Recommendations Identified
  • Now Identify Deliverables
  • Collaboration is Critical
  • Efficient Use of Resources
  • Better Case for Funding

11
ETP Global Animal HealthImplementation of the SRA
Next stage
12
ETP Global Animal HealthAction plan
  • Introduction
  • Developing the action plan
  • Overview of the Action Plan
  • Chapter 1 Introduction
  • Chapter 2 Themes
  • Chapter 3 Priority Diseases
  • Way Forward

13
ETP Global Animal HealthAction plan
  • Steering Council5 July 2006
  • Discussed the implementation plan
  • Decided to call it an action plan
  • Agreed to establish working groups
  • Agreed to call them co-ordination groups
  • Secretariat and EB to decide members
  • Agreed to add a 4th to cover Global Partnerships

14
ETP Global Animal Health Action
PlanCo-ordination Groups
  • Terms of Reference
  • Consider how the recommendations in each of the
    themes can be implemented and establish who
    should be responsible.
  • Set out the deliverables for each of the
    recommendations.
  • Provide details of performance measure,
    milestones and target dates for delivery of each
    of the recommendations.
  • Provide an analysis of potential cost and
    consider the strategy to acquire resources.
  • Where appropriate prepare documentation to be
    used by the funding organisations as the basis
    for the calls for proposals to deliver the
    necessary research.

15
ETP Global Animal HealthThe SRA 6 Themes
  • Prioritise animal diseases (8)
  • Conduct gap analyses (8)
  • Ensure high quality relevant (5)
    fundamental research
  • Identify the enabling factors to improve the rate
    of technology transfer (17)
  • Consider regulatory/societal issues (18)
  • Maintain a global perspective (5)

CG1
C G 2
C G 3
C G 4
16
ETP Global Animal Health Action Plan Meetings
  • 16 Nov 06 CG1 Carolin Schumacher
  • 17 Nov 06 CG3 Steve Dean
  • 20 Nov 06 CG2 Paul van Aarle
  • 21 Nov 06 CG4 Christianne Bruscke

17
Action PlanCo-0rdination Group 1
  • Chair Carolin Schumacher
  • Secretariat Technology Platform
    Secretariat
  • Aim of the Implementation Group
  • To develop an action plan for the recommendations
    of themes 1 2 and 3 in the SRA to assist in
    enabling the Global Animal Health Platform to
    achieve the aims of the platform. This is to
    facilitate and accelerate the development and
    distribution of the most effective tools for
    controlling animal diseases of major importance
    to Europe and the rest of the world.

18
ETP Global Animal HealthAction Plan
  • Series of action points identified as follows-
  • What is to be delivered
  • How is it to be delivered
  • Who is responsible for the delivery
  • Who will deliver it
  • How will it be funded
  • What are the milestones and target dates
  • What are the indicators of success
  • What are the risks

19
ETP Global Animal Health Action Plan
  • Establish Costs of Research
  • Establish Timelines for Research
  • Who should carry out Research?
  • Who should Fund Research?
  • Need to conduct Research on Disease
    Prioritisation Model (Chapter 2) as first step
  • Need to complete Gap Analysis (Chapter 3) as
    second step

20
ETP Global Animal Health Action Plan
Recommendations
21
ETP Global Animal Health Action Plan for SRA
recommendations
  • 1. Recommendation number(s)
  • Single or in groups depending on the most
    effective mechanism to deal with the subject
  • 2. Objective
  • What is to be delivered?
  • 3. Tasks
  • What are the specific tasks involved?
  • 4. Milestones /timetable
  • What are the milestones and target dates/ short
    ,medium or long term. i.e. 1,5,10 years
  • 5. Outputs and deliverables
  • What are the indicators of success?
  • What are the risks?
  • How is it to be delivered?
  • Who is responsible for the delivery?
  • Who will deliver it?
  • 6. Monitoring.
  • 7. Funding
  • 7a Funding required
  • 7b Funding sources
  • How will it be funded?

.
22
ETP Global Animal HealthAction plan
  • Introduction
  • Developing the action plan
  • Overview of the Action Plan
  • Chapter 1 Introduction
  • Chapter 2 Themes
  • Chapter 3 Priority Diseases
  • Way Forward

23
ETP Global Animal HealthAction plan
  • Overview of the plan
  • Chapter 1
  • Introduction
  • Structure
  • Funding
  • Management
  • Chapter 2
  • Themes Recommendations within themes
  • Detailed Proposals

24
ETP Global Animal HealthAction plan
  • Overview of the plan
  • Chapter 3
  • Prioritisation Model
  • Disease Information
  • Gap Analysis
  • Annex 1 Categories of Disease
  • Annex 2 Prioritisation Model
  • Annex 3 Bluetongue Disease Information
  • Annex 4 Bluetongue Gap Analysis

25
ETP Global Animal HealthAction plan
  • Introduction
  • Developing the action plan
  • Structure of the Action Plan
  • Chapter 1 Introduction
  • Chapter 2 Themes
  • Chapter 3 Priority Diseases
  • Way Forward

26
ETP Global Animal HealthAction plan
  • Chapter 1
  • The Action plan is intended to explain the
    research and information gathering exercises that
    need to be completed to deliver the
    recommendations in the SRA. It will also act as a
    communications tool explaining the specific steps
    that need to be taken to deliver on the Vision
    and the SRA.

27
ETP Global Animal HealthAction plan
  • Chapter 1
  • The first stage is to identify and prioritise the
    diseases of importance as recommended in Theme 1
    of the SRA.
  • The second stage contained in Theme 2 of the SRA
    is to assess the gaps in the knowledge and
    understanding of these diseases and to identify
    where research needs to be targeted. At the same
    time the gaps in the availability of products
    must be evaluated.

28
ETP Global Animal HealthAction plan
  • Chapter 1 Key Components
  • A number of components. These include,
  •  Identify the desired outcomes
  • The actions to achieve them
  • Agree timing and set milestones
  • Assign lead responsibility and supporting
    activities
  • Suggest funding sources
  • Prioritise as high or medium and timescale as
    immediate, medium term or long term.

29
ETP Global Animal HealthAction plan
  • Chapter 1
  • The SRA serves to provide an input for-
  •  
  • Future EC Framework Programmes which will involve
    close cooperation with EC, Member States and
    European Parliament representatives.
  •  
  • Future national research programmes where it will
    provide better opportunities to align and
    coordinate national programmes
  •  
  • Public/private research partnerships exploring
    ways to develop an integrated approach to
    developing new tools to control animal diseases.
  •  
  • Industry which has an important role working in
    partnership to develop new products, which can be
    delivered in the field.

30
ETP Global Animal HealthAction plan
  • Funding Management
  • Input to FP 7
  • Coordinate National Programmes
  • Promote Public/Private Partnerships
  • Involve Industry
  • SC to review Plan over time
  • Advisory group on Funding? consider
  • Experts to develop proposals for each Disease
  • Mirror Groups will play an important role

31
ETP Global Animal HealthAction plan
  • Introduction
  • Developing the action plan
  • Structure of the Action Plan
  • Chapter 1 Introduction
  • Chapter 2 Themes
  • Chapter 3 Priority Diseases
  • Way Forward

32
ETP Global Animal HealthThe SRA Six Themes
  • Strategically important issues
  • High societal relevance
  • Linked to Europes future growth,
    competitiveness, and sustainability
  • Dependant upon major research and
    technological advances
  • Medium to long-term scope
  • Important consequences for animal health
    research
  • Aligned with other Community policies and
    strategies
  • Significance for developing world

4 Improve Technology Transfer 17
5 Regulatory Societal Issues 8
1 Prioritise animal diseases 8
3 Fundamental research 5
6 Global Perspective 5
2 Gap Analysis 8
SRA
Finalised and submitted to the EU Commission in
May 2006
33
Action PlanFirst Stages
  • The first stage is to identify and prioritise the
    diseases of importance. The second stage is to
    assess the gaps in the knowledge and
    understanding of these diseases to identify where
    research needs to be targeted. At the same time
    the gaps in the availability of products will be
    evaluated. With the implementation of the
    recommendations from these two themes it will be
    possible to select priority diseases and identify
    the research needed to fill the gaps in knowledge
    along with the actions needed to develop new and
    improved tools for control of those diseases.

34
ETP Global Animal HealthAction plan Chapter 2
  • SRA Recommendations
  • Format in the action plan
  • SRA Recommendation
  • Deliverables
  • Tasks
  • Priority
  • Funding
  • Character of work
  • Lead organisation

35
Prioritsation of diseases
  • SRA Recommendations 1, 2,
  •  
  • Objective A method of prioritising animal
    diseases and zoonoses would enable funders to
    focus research in a manner which would allow the
    objectives of the ETPGAH to be met. To achieve
    this, a methodology is required which could
    provide a consistent and acceptable means of
    prioritising animal diseases and infections of
    major importance for the EU and worldwide.
    Further development of the prototype is needed to
    takes account of the overall level of risk of a
    given animal disease, the availability of
    suitable products or technology, the feasibility
    of control, the impact on economies, human
    health, food safety and public/consumer
    perception, etc. The process should be developed
    to a stage where the model is peer reviewed and
    used by decision makers as a decision support
    tool.

36
Prioritsation of diseases
  • Deliverables The main deliverables will be-
  • A working model for prioritisation which is peer
    reviewed and accepted by funders.
  • Publication of the prioritisation model
  • Production of peer reviewed prioritised list of
    diseases of importance
  • Publication of the list
  • Ultimately an IT solution with an interactive
    model
  • Regular use of the model to determine funding
    priorities

37
Prioritsation of diseases
  • Tasks
  • Finalise and peer review the criteria identified
    for assessment and the scores to be allocated to
    each of the criteria for use in the model
  • Provide an evidence base for each disease by the
    collection of information in a standard format
    which can be converted into scores.
  • Score each disease against the criteria to
    identify the importance of the disease to Europe
  • Further development of the paper based
    prioritisation model
  • Develop an IT based decision support tool
  • Produce an interactive tool to help with
    prioritisation of research funding.

38
Prioritsation of diseases
  • Priority High and immediate
  • Funding National Funders, EC Framework 7
    Cooperation,
  • Character of work specific project, applied
    research, decision support tool
  • Lead Organisation ETPGAH

39
ETP Global Animal HealthAction plan Chapter 2
  • SRA Recommendations
  • Have we got the layout correct
  • Have we covered all the issues
  • For each theme and item have we got the
    comprehensive objective
  • Are the deliverables acceptable, is anything
    missing, are they to ambitious
  • Are the tasks correct to deliver the objectives
  • What about the priority, method, classification
    for each
  • Funding are they correctly identified
  • Is the character classification correct
  • Who should lead.

40
ETP Global Animal HealthAction plan Chapter 2
  • Theme 1 Prioritisation of Animal Diseases
    Infections
  • 1.1 Prioritisation of Diseases (1-3-03)
  • 1.2 Emerging Threats to Europe (1-3-05, 1-3-06,
    1-1-05)
  • 1.3 Wildlife Diseases (1-3-04, 1-1-05)
  • 1.4 Supporting Activities (advice, coordination,
    partnerships)

41
ETP Global Animal HealthAction plan Chapter 2
  • Theme 2 Gap Analysis
  • 2.1 Gap Analysis for Priority Diseases (1-3-02,
    1-4-17)
  • 2.2 Gap Analysis of New Technologies (1-3-02)
  • 2.3 Gap Analysis of Current Research (1-3-02)
  • 2.4.Gap Analysis of Available Products

42
ETP Global Animal HealthAction plan Chapter 2
  • Theme 3 Fundamental Science
  • 3.1. Support and Strengthen Fundamental Sciences
    in the EU
  • 3.2. Establish a European Centre for Epidemiology
    and Infectious Diseases.
  • 3.3 Specific Requirements for Fundamental
    Research

43
ETP Global Animal HealthAction plan Chapter 2
  • Theme 4 Enabling Factors
  • 4.1. Quality Assurance
  • 4.2. Intellectual Property rights
  • 4.3. Overcoming Barriers to Technology Transfer
  • 4.4. Networks and Centres of Excellence
  • 4.5. Education and training
  • 4.6. Infrastructure

44
ETP Global Animal HealthAction plan Chapter 2
  • Theme 5 Regulatory and Societal issues
  • 5.1. Regulatory issues
  • 5.1.1 Drivers for Regulation
  • 5.1.2 Developing and effective Risk Benefit
    assessment methodology
  • 5.1.3 Modernising Guidelines and monographs
  • 5.1.4 Relevance and importance of Environmental
    Risk Assessment
  • 5.3.5 Barriers to harmonisation
  • 5.2. Diagnostic Tests
  • 5.3. Societal issues
  • 5.4. Community Animal Health Policy (CAHP)

45
ETP Global Animal HealthAction plan Chapter 2
  • Theme 6 Global Partnerships.
  • 6.1 Introduce Joint Research Programmes
  • 6.2 Provide Sustainable Financial Support
  • 6.3 Promote Research Partnerships

46
ETP Global Animal HealthAction plan
  • Introduction
  • Developing the action plan
  • Structure of the Action Plan
  • Chapter 1 Introduction
  • Chapter 2 Themes
  • Chapter 3 Priority Diseases
  • Way Forward

47
ETP Global Animal HealthAction plan
  • Chapter 3
  • Chapter 3 Research Requirements for Priority
    Diseases
  • 3.1 Introduction
  • 3.2 Prioritisation of diseases
  • 3.2.1 Initial stages
  • 3.2.2 Categories for diseases
  • 3.2.3 Prioritisation model
  • 3.2.4 Future action on prioritisation.
  • 3.3. Research Requirements for the priority
    diseases. (sum of gaps)
  • 3.3.1 Initial stages.
  • 3.3.2. Development of the gap analysis
  • 3.3.3 Bluetongue as an example
  • 3.3.4 Future action on requirements.

48
ETP Global Animal HealthAction plan
  • Chapter 3
  • 3.2 Prioritisation of diseases
  • 3.2.2 Categories for diseases
  • .

49
ETP Global Animal HealthAction plan Theme 1
Prioritise animal diseases
  • Was the original list the correct method of
    prioritisation?
  • Can the diseases be prioritised in a more logical
    manner?
  • How do we deal with multiple disease complexes.
  • As well as prioritising diseases could we
    prioritise possible success.

50
ETP Global Animal HealthAction plan
  • Chapter 3
  • 3.2 Prioritisation of diseases
  • 3.2.2 Categories for diseases
  • Group 1Epizootic diseases and diseases for
    surveillance
  • African Horse Sickness
  • African Swine Fever
  • Avian Influenza
  • Bluetongue
  • Contagious Bovine Pleuro Pneumonia
  • Classical Swine Fever
  • Foot Mouth Disease
  • Peste des Petits Ruminants
  • Rift Valley Fever
  • Ruminant Pox Virus
  • Swine Vesicular Disease
  • West-Nile Virus
  • .

51
ETP Global Animal HealthAction plan
  • Chapter 3
  • 3.2 Prioritisation of diseases 3.2.2
    Categories for diseases
  • Group 2  Zoonoses and food-borne diseases
  • Rabies
  • Nipah
  • Anthrax
  • Brucellosis
  • Bovine Tuberculosis
  • Q Fever
  • Trypanosomiasis
  • Leishmaniasis
  • Leptospirosis
  • Chlamydia
  • Cystercicosis
  • Echinoccocus
  • Food-borne bacterial Salmonella
  • E. Coli
  • Campylobacter
  • Cryptosporidium

52
ETP Global Animal HealthAction plan
  • Chapter 3
  • 3.2 Prioritisation of diseases 3.2.2
    Categories for diseases
  • Group 3 Major food-producing animal disease
    complexes
  • Parasitic gastro-intestinal diseases
  • Liver Fluke
  • Coccidiosis
  • Nematodes
  • Paratuberculosis (Johnes)
  • Mastitis  Staph.aureus mastitis
  • Environmental/Streptococcal mastitis
  • Small ruminant mastitis
  • Swine enteric
  • Respiratory Swine
  • PRRS CG3 HN
  • PCV II
  • SIV
  • A. pleuropneumonia
  • Mycoplasma
  • Respiratory Bovine

53
ETP Global Animal HealthAction plan
  • EPIDEMIOLOGY AND RISK
  • Speed of spread
  • Number of species involved
  • Persistence of infectious agent
  • Spreading potential to susceptible populations
  • Wildlife diseases risk potential threat to animal
    health and public health
  • Disease Knowledge
  • Wildlife diseases that are at threat
  • Dynamic (temporal, spatial, species variability
  • IMPACT ON WIDER SOCIETY
  • Disease Impact on Production
  • Economic direct impact (including cumulative cost
    eg enzootic vs epizootic)
  • Economic indirect impact (social, trade)
  • Impact on specific production and supply channels
  • Security of food supply/Benefit for developing
    world

54
ETP Global Animal HealthAction plan Criteria
  • IMPACT ON PUBLIC HEALTH
  • Impact on Public Health and Food Safety
  • Risk of occurrence
  • Impact of occurrence
  • IMPACT ON INTERNATIONAL TRADE
  • Impact on International Trade and EC trade due
    to existing regulations
  • CONTROL MEASURES
  • Effective prevention and control practices
  • Tools for surveillance
  • Tools for prevention crisis
  • Tools for control and implementation
  •  
  • Success of prevention and control in other
    countries
  • Technology (Vaccine/Treatment) / Tool
    Availability
  • Commercial Diagnostic Tools Availability

55
ETP Global Animal HealthAction plan
  • Introduction
  • Developing the action plan
  • Structure of the Action Plan
  • Chapter 1 Introduction
  • Chapter 2 Themes
  • Chapter 3 Priority Diseases
  • Way Forward

56
Action Plan Conclusions
  • Timescale 2007
  • 19 April S/C Amendments
  • 7 May Redraft with agreed changes
  • 11 May Revised action plan to all stakeholders
    for comments
  • 31 May Deadline for comments
  • 8 June Redrafted version to the E/B for
    endorsement
  • 30 June agreed final version for 2007

57
Action Plan Conclusions
  • Once the Action Plan is completed and agreed with
    stakeholders the platform will be responsible for
    monitoring progress and undertaking an annual
    review of activities.

58
Action Plan Conclusions
  • 1. The plan is intended to be a flexible working
    document, subject to regular review and up dating
    by the Steering Council of the ETPGAH to ensure
    that the SRA is on target and that the
    recommendations are being delivered.
  • 2. The Steering Council will evaluate the success
    of the platform in meeting its primary aims
    linked to the Lisbon agenda of improving the
    competitiveness of Europe.
  • 3. The success of the platform in delivering new
    and improved tools for the control of major
    diseases will also be measured

59
ETP Global Animal HealthUseful links for
information
  • CORDIS Web Site
  • http//cordis.europa.eu.int/technology-platforms/h
    ome_en.html
  • CORDIS partner search http//fp6.cordis.lu/fp6/pa
    rtners.cfm
  • Seventh Framework Programmehttp//europa.eu.int/
    comm/research/future/index en.cfm
  • IFAH Global Animal Health Platform
  • www.ifah.be/europe/euplatform/platform.htm

60
ETPGAH Contact Details
  • Thank You!
  • European Technology Platform for Global Animal
    Health (ETPGAH)
  • Rue Defacqz, 1
  • 1000 Brussels, Belgium
  • Tel. 32 (0)2 543 7560
  • Fax 32 (0)2 537 0049
  • E-mail info_at_ifahsec.org
  • Website www.ifahsec.org/Europe/EUPlatform/Platfor
    m.htm
Write a Comment
User Comments (0)
About PowerShow.com